tamoxifen citrate

Poland

Drugs containing this active substance

  • TAMOXIFEN EGIS

    This medicine is intended for the treatment of breast cancer.

    Form: tablets

    Active substance Dosage
    tamoxifen citrate 30.4 mg

    ATC: L02BA01

    Manufacturer: Egis Pharmaceuticals PLC

  • The medicine is used to treat advanced breast cancer with metastases or as adjuvant therapy following primary treatment of this cancer.

    Form: tablets, film-coated

    Active substance Dosage
    tamoxifen citrate 20 mg

    ATC: L02BA01

    Manufacturer: Salutas Pharma GmbH

  • The medicinal product is used for the treatment of breast cancer. It may be administered alone or in combination with other anticancer drugs.

    Form: tablets

    Active substance Dosage
    tamoxifen citrate 15.2 mg

    ATC: L02BA01

    Manufacturer: Ebewe Pharma GmbH Nfg. KG, Lek Pharmaceuticals d.d., Salutas Pharma GmbH